## Core Concept
Myopia, or nearsightedness, is a refractive error where close objects are seen clearly but distant objects appear blurry. This condition occurs when the eyeball is too long or the cornea is too steep, causing light to focus in front of the retina instead of directly on it. Treatment options for myopia aim to correct this refractive error.

## Why the Correct Answer is Right
Atropine, **a muscarinic receptor antagonist**, is used in the treatment of myopia, particularly in children, to slow down the progression of the condition. It works by temporarily paralyzing the ciliary muscles, which control the shape of the lens. This paralysis leads to a decrease in the eye's ability to focus on near objects, thereby reducing the stimulus for myopia progression. The use of atropine in myopia management is supported by research indicating its effectiveness in slowing myopia progression in children.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and does not provide a valid choice for consideration.
- **Option B:** This option is also blank and does not offer a viable treatment for myopia.
- **Option C:** Similarly, this option is blank and lacks relevance to myopia treatment.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that atropine **0.5% or 1% eye drops** are specifically used for their **myopia control effects** in children. This treatment approach is gaining recognition and is supported by clinical trials showing a reduction in myopia progression. It's essential to remember that while atropine can be effective, its use must be monitored due to potential side effects like photophobia and blurred near vision.

## Correct Answer Line
**Correct Answer: D. Atropine**.